Analysts – Health

After Pfizer’s vaccine data, analysts say COVID drug makers face questions about long-term sales prospects

While much of the world focused on Pfizer and BioNTech’s positive COVID-19 vaccine news on Monday, analysts started gaming out potential ripple effects, namely for companies making coronavirus therapeutics. A promising COVID-19 vaccine is obviously good news for drugmakers and the world at large, but companies developing and selling coronavirus treatments could see lower sales down the line, Barclays analysts wrote… Read More »

One Medicare Trust Fund May Run Dry By As Early As 2022, Analysts Warn : Shots – Health News – NPR

Enlarge this image Funding is shrinking for Medicare’s Part A trust fund, which pays for hospitalization and in-patient care. The funding largely comes from a 1.45% payroll tax paid by employees and employers. pablohart/Getty Images hide caption toggle caption pablohart/Getty Images Everyone involved even tangentially in health care today is consumed by the coronavirus pandemic,… Read More »